The NCR Foundation is providing UNICEF with a grant to fund a new on-site Oxygen-Generation Plant (OGP) that will deliver medical-grade oxygen needed to support a 500-bed hospital in India. Additionally, the financial assistance will go toward funding 10,000 COVID-19 vaccines for front-line workers and vulnerable populations in India and the Philippines. NCR and the NCR Foundation are continuing to work to provide additional assistance and support to countries impacted around the globe; like Brazil and others.
The World Health Organization today reported that India alone accounted for 46% of new COVID-19 cases recorded last week and 25% of all deaths as hospitals continue running out of beds and oxygen.
“While the impact of the pandemic has lessened in the United States, some of our NCR communities in India, the Philippines and other parts of the world are suffering through a devastating escalation in illness and are struggling to procure some key medical resources,” said Tim Oliver, Chair of the NCR Foundation and Executive Vice President, Chief Financial Officer at NCR Corporation. “NCR and the NCR Foundation are committed to supporting our global community of employees and customers in their urgent fight against the virus.”
To find out more about UNICEF’s work to end the pandemic and to donate, visit www.unicefusa.org.
About NCR Corporation
NCR Corporation (NYSE: NCR) is a leading software- and services-led enterprise provider in the financial, retail and hospitality industries. NCR is headquartered in Atlanta, Ga., with 36,000 employees globally. NCR is a trademark of NCR Corporation in the United States and other countries.
About NCR Foundation
The NCR Foundation was established in 1953 to support community needs consistent with NCR’s mission. As NCR Corporation evolved into a leading software- and services led enterprise provider in the financial, retail and hospitality industries, the NCR Foundation has evolved its grant strategy to build stronger communities by investing with nonprofit partners.
Web site: www.ncr.com/about/foundation